Compare peptides
Put two entries side by side — evidence, mechanism, risks, and community claims.
SS-31
Clinical
Research chemical
Summary
Mitochondria-targeting tetrapeptide (elamipretide) studied for bioenergetic and rare disease indications.
Categories
Mitochondrial, Longevity
Mechanism
Binds cardiolipin, stabilizing electron transport efficiency and reducing pathological ROS in dysfunctional mitochondria models.
Half-life
Short; clinical regimens often daily subcutaneous
Routes
Subcutaneous injection
Legal / access
Elamipretide has been in clinical development with mixed regulatory outcomes by indication; not a general wellness approved drug for all uses.
Key risks
- Injection-site reactions
- Eosinophilia in some studies
- Trial-specific adverse events
Common claims
- More cellular energy
- Recovery and endurance
- Neuro/heart aging support
Select peptide B